share_log

OTR Acquisition Corp. Reports Filed Confidential Submission Of S-4 Registration Statement Related To SPAC Deal With Comera Life Sciences

OTR Acquisition Corp. Reports Filed Confidential Submission Of S-4 Registration Statement Related To SPAC Deal With Comera Life Sciences

OTR Acquisition Corp.报告与科美拉生命科学公司的交易有关的S-4注册声明的保密提交
Benzinga Real-time News ·  2022/02/04 08:06

OTR Acquisition Corp. (NASDAQ:OTRAU, OTRA and OTRAW))), a publicly traded special purpose acquisition company (SPAC), today announced the confidential submission with the U.S. Securities and Exchange Commission ("SEC") of a draft registration statement on Form S-4 (the "Registration Statement") relating to its previously announced proposed business combination with Comera Life Sciences, Inc.

Otr Acquisition Corp.(纳斯达克代码：OTRAU，OTRA and OTRAW)是一家上市的特殊目的收购公司(SPAC)，今天宣布向美国证券交易委员会(“美国证券交易委员会”)保密提交一份S-4表格注册声明草案(下称“注册声明”)，涉及其先前宣布的与Comera生命科学公司拟议的业务合并。

This press release features multimedia. View the full release here:

这份新闻稿以多媒体为特色。点击此处查看完整版本：

In addition, the investor call with Comera and OTR has been rescheduled to Tuesday, Feb. 8 at 8:30 a.m. EST (from previous date and time of Friday, Feb. 4 at 8:30 a.m. EST) to discuss the proposed business combination. An audio webcast of the event will be available on the OTR Investor Relations website at

此外，与Comera和OTR的投资者电话会议已重新安排到2月8日星期二上午8：30。东部时间(来自之前的日期和时间，2月4日，星期五，上午8：30EST(EST：行情)讨论拟议的业务合并.此次活动的音频网络直播将在OTR投资者关系网站上提供，网址为：

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发